In this report we aimed to present the nonthreatening experience of patients diagnosed with Common variable immunodeficiency (CVID) included in the National Rare Disease Program …
CH Drabe, ABE Hansen, LD Rasmussen… - Infectious …, 2021 - Taylor & Francis
Background Manifestations and outcomes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are not well documented in patients with common variable …
The risk of severe adult respiratory coronavirus-2 (SARS-CoV-2) infection and the course of the infection among individuals with common variable immunodeficiency (CVID) relative to …
N Weifenbach, A Jung, S Lötters - Immunity, Inflammation and …, 2021 - Wiley Online Library
Introduction In patients with common variable immunodeficiency (CVID), immunological response is compromised. Knowledge about COVID‐19 in CVID patients is sparse. We …
A Al-Hakim, M Kacar, S Savic - Journal of Clinical Medicine, 2024 - mdpi.com
Common Variable Immunodeficiency (CVID) is a heterogeneous primary immunodeficiency disorder characterised by impaired antibody production, leading to recurrent infections and …
T Ferenc, T Vilibić-Čavlek - Acta clinica Croatica, 2022 - hrcak.srce.hr
Coronavirus disease 2019 (COVID-19) is an emerging infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The usual presentation of the …
JR Greenmyer, AY Joshi - Journal of clinical immunology, 2022 - Springer
Common variable immunodeficiency (CVID), caused by failure of B-cell differentiation with subsequent defective immunoglobulin production, presents heterogeneously as recurrent …
S Lesichkova, S Mihailova, E Naumova… - … European Journal of …, 2022 - termedia.pl
The association of immunocompromised patients and severity of COVID-19 infection is not well established. According to the Centers for Disease Control and Prevention (CDC) …
D Nye, L Kaminsky, T Al-Shaikhly - Journal of Allergy and Clinical …, 2022 - jacionline.org
Methods We queried the TriNetX COVID-19 Research Network (n= 84,961,620) for patients with CVID on immunoglobulin replacement diagnosed with COVID-19 (01/20/2020 …